Physician profile
Sunghwan Byun
NPI 1780925792
$4,918.00
in general payments reported to CMS, 2019-2025
9 companies · $2,837 in 2025
The $2,837 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,925 · 2021: $83.45 · 2022: $72.00 · 2025: $2,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,509 · Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,509.42 |
| Food and Beverage | $327.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orpyx Medical Technologies INC. | $2,837.37 | 2025 | |
| Stryker Corporation | $1,713.31 | 2019-2021 | |
| Biocomposites INC | $120.05 | 2019 | |
| Grt US Holding, INC. | $72.00 | 2022 | |
| Paragon 28, INC. | $69.16 | 2021 | |
| Smith+Nephew, INC. | $64.82 | 2019 | |
| Wright Medical Technology, INC. | $20.09 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $13.70 | 2019 | |
| Orthofix Medical, INC. | $7.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunghwan Byun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.